Contact this trialFirst, we need to learn more about you.
NMDA Receptor Antagonist
Hydroxynorketamine for Neuropathic Pain
Recruiting0 awardsPhase 1 & 2
Chicago, Illinois
This trial will evaluate the effectiveness and duration of a single infusion of (2R,6R)-HNK on pain, physical function, pain interference, sleep disturbance and quality of life in patients with neuropathic pain.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service